Eagle Pharmaceuticals Inc (NASDAQ:EGRX)

41.48
Delayed Data
As of Apr 09
 +0.28 / +0.68%
Today’s Change
36.48
Today|||52-Week Range
56.16
-10.93%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Eagle Pharmaceuticals Inc have a median target of 46.00, with a high estimate of 52.00 and a low estimate of 46.00. The median estimate represents a +10.90% increase from the last price of 41.48.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Eagle Pharmaceuticals Inc. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.73
Sales
$45.1M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.70%
 
 
 
 
 
 
Growthannually -5.08%
 
 
 
 
 
 

Sales

Growthquarterly -9.73%
 
 
 
 
 
 
Growthannually 4.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.